Periodontitis is associated with disease severity and anti-double stranded DNA antibody and interferon-gamma levels in patients with systemic lupus erythematosus

لتحليل توافق شدة التهاب اللثة مع نشاط المرض، والأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة والمضاد الضوئي المناعي في مرضى الذئبة الحمامية المجموعية. في هذه الدراسة الرصدية المستعرضة، اخترنا ٦١ مريضا يعانون من مرض الذئبة الحمامية المجموعية (سن ١٨-٥٥ سنة) من مستشفى إندونيسي في مالانج. وأ...

Full description

Saved in:
Bibliographic Details
Published inJournal of Taibah University Medical Sciences Vol. 14; no. 6; pp. 560 - 565
Main Authors Gofur, Nanda R.P., Nurdiana, Nurdiana, Kalim, Handono, Handono, Kusworini
Format Journal Article
LanguageEnglish
Published Saudi Arabia Elsevier Ltd 01.12.2019
Taibah University
Elsevier
Subjects
Online AccessGet full text
ISSN1658-3612
1658-3612
DOI10.1016/j.jtumed.2019.09.005

Cover

Loading…
Abstract لتحليل توافق شدة التهاب اللثة مع نشاط المرض، والأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة والمضاد الضوئي المناعي في مرضى الذئبة الحمامية المجموعية. في هذه الدراسة الرصدية المستعرضة، اخترنا ٦١ مريضا يعانون من مرض الذئبة الحمامية المجموعية (سن ١٨-٥٥ سنة) من مستشفى إندونيسي في مالانج. وأجري الفحص السريري والاختبارات المعملية لتقييم نشاط المرض. وتم قياس شدة مرض الذئبة الحمامية المجموعية باستخدام مؤشر نشاطها، وقيست شدة التهاب اللثة باستخدام معايير مؤشر اللثة. كما تم تحديد مستويات الأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة والمضاد الضوئي المناعي باستخدام مقايسة الممتز المناعي المرتبط بالإنزيم (إلايسا). وتم قياس الكثافة البصرية على قارئ طبق آلي لـ ٤٥٠ نانومتر. كان متوسط عمر المصابين بمرض الذئبة الحمامية المجموعية ٢٩ سنة وكانت مدة المرض ٢.٨ سنة. ووجدنا أن ٥٤/٦١ (٨٨.٥٪) من المصابين بمرض الذئبة الحمامية المجموعية لديهم التهاب اللثة، بناءً على تقييم مؤشر اللثة. وكان لدى مرضى الذئبة الحمامية المجموعية مظاهر سريرية أخرى مثل التهاب الكلية الذئبي والتهاب الأوعية الدموية والتهاب المفاصل وأعراض الجلد والأغشية المخاطية والتعب والحمى ونقص الكريات البيضاء. تم تقييم شدة مرض الذئبة الحمامية المجموعية باستخدام مؤشر نشاط الذئبة الحمامية المجموعية بنتيجة متوسطة ١٧.٧ +/- ١٢.٧، ومتوسط نتيجة الأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة ومستوى المضاد الضوئي المناعي ١٢٢.٦ +/- ٨١ وحدة / مل، و١٤.٦+/- ١١.١٧ بيكوجرام / مل. كان هناك توافق إيجابي كبير ذو قيمة إحصائية بين درجة التهاب اللثة ونتيجة مؤشر نشاط الذئبة الحمامية المجموعية (معامل التوافق: ٠.٩٢٧) ومضادات الحمض النووي الريبي المختزل مزدوج الضفيرة (معامل التوافق: ٠.٩٤٧) ومضاد ضوئي مناعي (معامل التوافق: ٠.٩٥١). أظهرت دراستنا أن التهاب اللثة مرتبط بنشاط مرض الذئبة الحمامية المجموعية، والمؤشر الحيوي للشيخوخة المناعية. علاوة على ذلك، يمكن أن يكون المؤشر الحيوي للشيخوخة أداة يُعتمد عليها في توقع حالات التهابات اللثة وأساليب تطورها، واختيار أفضل علاج لالتهاب اللثة في مرضى الذئبة الحمامية المجموعية. To analyse the correlation between periodontitis severity and disease activity, anti-double stranded DNA (anti-dsDNA) antibody, and interferon-gamma (IFN-γ) levels in patients with systemic lupus erythematous (SLE). We selected 61 patients with SLE (age 18–55 years) selected from a hospital in Malang, Indonesia. Clinical examination and laboratory tests were performed to assess disease activity. The severity of SLE was measured using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), while periodontitis severity was measured according to the Periodontal Index (PI) criteria. Levels of anti-dsDNA and IFN-γ were determined using an enzyme-linked immunosorbent assay. Optical density at 450 nm was measured using an automated plate reader. The mean age of the subjects with SLE was 29 years, and mean disease duration was 2.8 years. Fifty-four of 61 (88.53%) subjects with SLE had periodontitis according to the PI. SLE subjects exhibited other clinical manifestations such as lupus nephritis, vasculitis, arthritis, mucocutaneous manifestation, fatigue, fever, and/or leukopenia. SLE severity was assessed according to the average SLEDAI score (17.70 ± 12.70), and average anti-dsDNA (122.6 ± 81.01 U/mL), and IFN-γ (14.64 ± 11.17 pg/mL) levels. There was a significantly positive correlation between periodontitis score and SLEDAI score (r = 0.927; p ≤ 0.0001), anti-dsDNA antibody (r = 0.948; p ≤ 0.0001), and IFN-γ (r = 0.951; p ≤ 0.0001) levels. Results of the present study demonstrated that periodontitis was associated with SLE disease activity, and was a biomarker of immune aging. Furthermore, this biomarker could be a reliable predictor of periodontal condition and prognosis of periodontitis and can also help in selecting the most appropriate treatment strategy for periodontitis in patients with SLE.
AbstractList لتحليل توافق شدة التهاب اللثة مع نشاط المرض، والأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة والمضاد الضوئي المناعي في مرضى الذئبة الحمامية المجموعية. في هذه الدراسة الرصدية المستعرضة، اخترنا ٦١ مريضا يعانون من مرض الذئبة الحمامية المجموعية (سن ١٨-٥٥ سنة) من مستشفى إندونيسي في مالانج. وأجري الفحص السريري والاختبارات المعملية لتقييم نشاط المرض. وتم قياس شدة مرض الذئبة الحمامية المجموعية باستخدام مؤشر نشاطها، وقيست شدة التهاب اللثة باستخدام معايير مؤشر اللثة. كما تم تحديد مستويات الأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة والمضاد الضوئي المناعي باستخدام مقايسة الممتز المناعي المرتبط بالإنزيم (إلايسا). وتم قياس الكثافة البصرية على قارئ طبق آلي لـ ٤٥٠ نانومتر. كان متوسط عمر المصابين بمرض الذئبة الحمامية المجموعية ٢٩ سنة وكانت مدة المرض ٢.٨ سنة. ووجدنا أن ٥٤/٦١ (٨٨.٥٪) من المصابين بمرض الذئبة الحمامية المجموعية لديهم التهاب اللثة، بناءً على تقييم مؤشر اللثة. وكان لدى مرضى الذئبة الحمامية المجموعية مظاهر سريرية أخرى مثل التهاب الكلية الذئبي والتهاب الأوعية الدموية والتهاب المفاصل وأعراض الجلد والأغشية المخاطية والتعب والحمى ونقص الكريات البيضاء. تم تقييم شدة مرض الذئبة الحمامية المجموعية باستخدام مؤشر نشاط الذئبة الحمامية المجموعية بنتيجة متوسطة ١٧.٧ +/- ١٢.٧، ومتوسط نتيجة الأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة ومستوى المضاد الضوئي المناعي ١٢٢.٦ +/- ٨١ وحدة / مل، و١٤.٦+/- ١١.١٧ بيكوجرام / مل. كان هناك توافق إيجابي كبير ذو قيمة إحصائية بين درجة التهاب اللثة ونتيجة مؤشر نشاط الذئبة الحمامية المجموعية (معامل التوافق: ٠.٩٢٧) ومضادات الحمض النووي الريبي المختزل مزدوج الضفيرة (معامل التوافق: ٠.٩٤٧) ومضاد ضوئي مناعي (معامل التوافق: ٠.٩٥١). أظهرت دراستنا أن التهاب اللثة مرتبط بنشاط مرض الذئبة الحمامية المجموعية، والمؤشر الحيوي للشيخوخة المناعية. علاوة على ذلك، يمكن أن يكون المؤشر الحيوي للشيخوخة أداة يُعتمد عليها في توقع حالات التهابات اللثة وأساليب تطورها، واختيار أفضل علاج لالتهاب اللثة في مرضى الذئبة الحمامية المجموعية. To analyse the correlation between periodontitis severity and disease activity, anti-double stranded DNA (anti-dsDNA) antibody, and interferon-gamma (IFN-γ) levels in patients with systemic lupus erythematous (SLE). We selected 61 patients with SLE (age 18–55 years) selected from a hospital in Malang, Indonesia. Clinical examination and laboratory tests were performed to assess disease activity. The severity of SLE was measured using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), while periodontitis severity was measured according to the Periodontal Index (PI) criteria. Levels of anti-dsDNA and IFN-γ were determined using an enzyme-linked immunosorbent assay. Optical density at 450 nm was measured using an automated plate reader. The mean age of the subjects with SLE was 29 years, and mean disease duration was 2.8 years. Fifty-four of 61 (88.53%) subjects with SLE had periodontitis according to the PI. SLE subjects exhibited other clinical manifestations such as lupus nephritis, vasculitis, arthritis, mucocutaneous manifestation, fatigue, fever, and/or leukopenia. SLE severity was assessed according to the average SLEDAI score (17.70 ± 12.70), and average anti-dsDNA (122.6 ± 81.01 U/mL), and IFN-γ (14.64 ± 11.17 pg/mL) levels. There was a significantly positive correlation between periodontitis score and SLEDAI score (r = 0.927; p ≤ 0.0001), anti-dsDNA antibody (r = 0.948; p ≤ 0.0001), and IFN-γ (r = 0.951; p ≤ 0.0001) levels. Results of the present study demonstrated that periodontitis was associated with SLE disease activity, and was a biomarker of immune aging. Furthermore, this biomarker could be a reliable predictor of periodontal condition and prognosis of periodontitis and can also help in selecting the most appropriate treatment strategy for periodontitis in patients with SLE.
الملخص: أهداف البحث: لتحليل توافق شدة التهاب اللثة مع نشاط المرض، والأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة والمضاد الضوئي المناعي في مرضى الذئبة الحمامية المجموعية. طرق البحث: في هذه الدراسة الرصدية المستعرضة، اخترنا ٦١ مريضا يعانون من مرض الذئبة الحمامية المجموعية (سن ١٨-٥٥ سنة) من مستشفى إندونيسي في مالانج. وأجري الفحص السريري والاختبارات المعملية لتقييم نشاط المرض. وتم قياس شدة مرض الذئبة الحمامية المجموعية باستخدام مؤشر نشاطها، وقيست شدة التهاب اللثة باستخدام معايير مؤشر اللثة. كما تم تحديد مستويات الأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة والمضاد الضوئي المناعي باستخدام مقايسة الممتز المناعي المرتبط بالإنزيم (إلايسا). وتم قياس الكثافة البصرية على قارئ طبق آلي لـ ٤٥٠ نانومتر. النتائج: كان متوسط عمر المصابين بمرض الذئبة الحمامية المجموعية ٢٩ سنة وكانت مدة المرض ٢.٨ سنة. ووجدنا أن ٥٤/٦١ (٨٨.٥٪) من المصابين بمرض الذئبة الحمامية المجموعية لديهم التهاب اللثة، بناءً على تقييم مؤشر اللثة. وكان لدى مرضى الذئبة الحمامية المجموعية مظاهر سريرية أخرى مثل التهاب الكلية الذئبي والتهاب الأوعية الدموية والتهاب المفاصل وأعراض الجلد والأغشية المخاطية والتعب والحمى ونقص الكريات البيضاء. تم تقييم شدة مرض الذئبة الحمامية المجموعية باستخدام مؤشر نشاط الذئبة الحمامية المجموعية بنتيجة متوسطة ١٧.٧ +/- ١٢.٧، ومتوسط نتيجة الأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة ومستوى المضاد الضوئي المناعي ١٢٢.٦ +/- ٨١ وحدة / مل، و١٤.٦+/- ١١.١٧ بيكوجرام / مل. كان هناك توافق إيجابي كبير ذو قيمة إحصائية بين درجة التهاب اللثة ونتيجة مؤشر نشاط الذئبة الحمامية المجموعية (معامل التوافق: ٠.٩٢٧) ومضادات الحمض النووي الريبي المختزل مزدوج الضفيرة (معامل التوافق: ٠.٩٤٧) ومضاد ضوئي مناعي (معامل التوافق: ٠.٩٥١). الاستنتاجات: أظهرت دراستنا أن التهاب اللثة مرتبط بنشاط مرض الذئبة الحمامية المجموعية، والمؤشر الحيوي للشيخوخة المناعية. علاوة على ذلك، يمكن أن يكون المؤشر الحيوي للشيخوخة أداة يُعتمد عليها في توقع حالات التهابات اللثة وأساليب تطورها، واختيار أفضل علاج لالتهاب اللثة في مرضى الذئبة الحمامية المجموعية. Abstract: Objectives: To analyse the correlation between periodontitis severity and disease activity, anti-double stranded DNA (anti-dsDNA) antibody, and interferon-gamma (IFN-γ) levels in patients with systemic lupus erythematous (SLE). Methods: We selected 61 patients with SLE (age 18–55 years) selected from a hospital in Malang, Indonesia. Clinical examination and laboratory tests were performed to assess disease activity. The severity of SLE was measured using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), while periodontitis severity was measured according to the Periodontal Index (PI) criteria. Levels of anti-dsDNA and IFN-γ were determined using an enzyme-linked immunosorbent assay. Optical density at 450 nm was measured using an automated plate reader. Results: The mean age of the subjects with SLE was 29 years, and mean disease duration was 2.8 years. Fifty-four of 61 (88.53%) subjects with SLE had periodontitis according to the PI. SLE subjects exhibited other clinical manifestations such as lupus nephritis, vasculitis, arthritis, mucocutaneous manifestation, fatigue, fever, and/or leukopenia. SLE severity was assessed according to the average SLEDAI score (17.70 ± 12.70), and average anti-dsDNA (122.6 ± 81.01 U/mL), and IFN-γ (14.64 ± 11.17 pg/mL) levels. There was a significantly positive correlation between periodontitis score and SLEDAI score (r = 0.927; p ≤ 0.0001), anti-dsDNA antibody (r = 0.948; p ≤ 0.0001), and IFN-γ (r = 0.951; p ≤ 0.0001) levels. Conclusion: Results of the present study demonstrated that periodontitis was associated with SLE disease activity, and was a biomarker of immune aging. Furthermore, this biomarker could be a reliable predictor of periodontal condition and prognosis of periodontitis and can also help in selecting the most appropriate treatment strategy for periodontitis in patients with SLE. الكلمات المفتاحية: الذئبة الحمامية المجموعية, التهاب اللثة, مقايسة الممتز المناعي المرتبط بالإنزيم (إلايسا), الأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة, المضاد الضوئي المناعي, Keywords: Anti-dsDNA antibody, ELISA, IFN-γ, Periodontitis, SLE
To analyse the correlation between periodontitis severity and disease activity, anti-double stranded DNA (anti-dsDNA) antibody, and interferon-gamma (IFN-γ) levels in patients with systemic lupus erythematous (SLE). We selected 61 patients with SLE (age 18-55 years) selected from a hospital in Malang, Indonesia. Clinical examination and laboratory tests were performed to assess disease activity. The severity of SLE was measured using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), while periodontitis severity was measured according to the Periodontal Index (PI) criteria. Levels of anti-dsDNA and IFN-γ were determined using an enzyme-linked immunosorbent assay. Optical density at 450 nm was measured using an automated plate reader. The mean age of the subjects with SLE was 29 years, and mean disease duration was 2.8 years. Fifty-four of 61 (88.53%) subjects with SLE had periodontitis according to the PI. SLE subjects exhibited other clinical manifestations such as lupus nephritis, vasculitis, arthritis, mucocutaneous manifestation, fatigue, fever, and/or leukopenia. SLE severity was assessed according to the average SLEDAI score (17.70 ± 12.70), and average anti-dsDNA (122.6 ± 81.01 U/mL), and IFN-γ (14.64 ± 11.17 pg/mL) levels. There was a significantly positive correlation between periodontitis score and SLEDAI score (r = 0.927; p ≤ 0.0001), anti-dsDNA antibody (r = 0.948; p ≤ 0.0001), and IFN-γ (r = 0.951; p ≤ 0.0001) levels. Results of the present study demonstrated that periodontitis was associated with SLE disease activity, and was a biomarker of immune aging. Furthermore, this biomarker could be a reliable predictor of periodontal condition and prognosis of periodontitis and can also help in selecting the most appropriate treatment strategy for periodontitis in patients with SLE.
To analyse the correlation between periodontitis severity and disease activity, anti-double stranded DNA (anti-dsDNA) antibody, and interferon-gamma (IFN-γ) levels in patients with systemic lupus erythematous (SLE).OBJECTIVESTo analyse the correlation between periodontitis severity and disease activity, anti-double stranded DNA (anti-dsDNA) antibody, and interferon-gamma (IFN-γ) levels in patients with systemic lupus erythematous (SLE).We selected 61 patients with SLE (age 18-55 years) selected from a hospital in Malang, Indonesia. Clinical examination and laboratory tests were performed to assess disease activity. The severity of SLE was measured using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), while periodontitis severity was measured according to the Periodontal Index (PI) criteria. Levels of anti-dsDNA and IFN-γ were determined using an enzyme-linked immunosorbent assay. Optical density at 450 nm was measured using an automated plate reader.METHODSWe selected 61 patients with SLE (age 18-55 years) selected from a hospital in Malang, Indonesia. Clinical examination and laboratory tests were performed to assess disease activity. The severity of SLE was measured using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), while periodontitis severity was measured according to the Periodontal Index (PI) criteria. Levels of anti-dsDNA and IFN-γ were determined using an enzyme-linked immunosorbent assay. Optical density at 450 nm was measured using an automated plate reader.The mean age of the subjects with SLE was 29 years, and mean disease duration was 2.8 years. Fifty-four of 61 (88.53%) subjects with SLE had periodontitis according to the PI. SLE subjects exhibited other clinical manifestations such as lupus nephritis, vasculitis, arthritis, mucocutaneous manifestation, fatigue, fever, and/or leukopenia. SLE severity was assessed according to the average SLEDAI score (17.70 ± 12.70), and average anti-dsDNA (122.6 ± 81.01 U/mL), and IFN-γ (14.64 ± 11.17 pg/mL) levels. There was a significantly positive correlation between periodontitis score and SLEDAI score (r = 0.927; p ≤ 0.0001), anti-dsDNA antibody (r = 0.948; p ≤ 0.0001), and IFN-γ (r = 0.951; p ≤ 0.0001) levels.RESULTSThe mean age of the subjects with SLE was 29 years, and mean disease duration was 2.8 years. Fifty-four of 61 (88.53%) subjects with SLE had periodontitis according to the PI. SLE subjects exhibited other clinical manifestations such as lupus nephritis, vasculitis, arthritis, mucocutaneous manifestation, fatigue, fever, and/or leukopenia. SLE severity was assessed according to the average SLEDAI score (17.70 ± 12.70), and average anti-dsDNA (122.6 ± 81.01 U/mL), and IFN-γ (14.64 ± 11.17 pg/mL) levels. There was a significantly positive correlation between periodontitis score and SLEDAI score (r = 0.927; p ≤ 0.0001), anti-dsDNA antibody (r = 0.948; p ≤ 0.0001), and IFN-γ (r = 0.951; p ≤ 0.0001) levels.Results of the present study demonstrated that periodontitis was associated with SLE disease activity, and was a biomarker of immune aging. Furthermore, this biomarker could be a reliable predictor of periodontal condition and prognosis of periodontitis and can also help in selecting the most appropriate treatment strategy for periodontitis in patients with SLE.CONCLUSIONResults of the present study demonstrated that periodontitis was associated with SLE disease activity, and was a biomarker of immune aging. Furthermore, this biomarker could be a reliable predictor of periodontal condition and prognosis of periodontitis and can also help in selecting the most appropriate treatment strategy for periodontitis in patients with SLE.
Author Handono, Kusworini
Nurdiana, Nurdiana
Kalim, Handono
Gofur, Nanda R.P.
AuthorAffiliation b Department of Pharmacology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
a Doctoral Program of Medical Science, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
d Department of Pathology Clinic, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
c Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
AuthorAffiliation_xml – name: c Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
– name: d Department of Pathology Clinic, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
– name: b Department of Pharmacology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
– name: a Doctoral Program of Medical Science, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
Author_xml – sequence: 1
  givenname: Nanda R.P.
  surname: Gofur
  fullname: Gofur, Nanda R.P.
  email: nanda.gofur@gmail.com
  organization: Doctoral Program of Medical Science, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
– sequence: 2
  givenname: Nurdiana
  surname: Nurdiana
  fullname: Nurdiana, Nurdiana
  organization: Department of Pharmacology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
– sequence: 3
  givenname: Handono
  surname: Kalim
  fullname: Kalim, Handono
  organization: Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
– sequence: 4
  givenname: Kusworini
  surname: Handono
  fullname: Handono, Kusworini
  organization: Department of Pathology Clinic, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31908645$$D View this record in MEDLINE/PubMed
BookMark eNqFks9u1DAQxiNUREvpGyCUI5cstpN4Yw5IVflXqQIOcLYm9mTXqyRebGerfRzelNlmi1oOIE0Uy_PN75Nn5nl2MvoRs-wlZwvOuHyzWWzSNKBdCMbVglGw-kl2xmXdFKXk4uTB-TS7iHHDGOOc1UKIZ9lpyRVrZFWfZb--YXDe-jG55GJOATF64yChzW9dWufWRYSIecQdSdM-h9HSl1xh_dT2lEiBrkj-_svlXaL1dla5MWHoMPixWMEwQN4ToyeXMd9CcjimOHvEfUw4OJP303aKOYZ9WuMAyccpvsiedtBHvDj-z7MfHz98v_pc3Hz9dH11eVOYWqhUNE0n5XLJEWujGgFlpYDVdgmmk0o2TDS8a1oLUjCmuGkqIYH0KFVbMW5UeZ5dz1zrYaO3wQ0Q9tqD03cXPqw0hORMj7qsK5SghIGqqmTJCdYQgwHhWq5KYr2bWduppSkZemmA_hH0cWZ0a73yOy1VxaQ8AF4fAcH_nDAmPbhosO9hRD9FLcqSHqBUyUn66qHXH5P7GZPg7SwwwccYsNPGJWq_P1i7XnOmDzulN3reKX3YKc0o2KG4-qv4nv-fsmMDaNy4cxh0NDRvg9YFNIla6v4N-A0ASuul
CitedBy_id crossref_primary_10_4103_jioh_jioh_205_20
crossref_primary_10_3389_fimmu_2024_1356714
crossref_primary_10_1111_jre_12936
crossref_primary_10_52711_0974_360X_2022_00151
Cites_doi 10.1101/gad.235184.113
10.1016/j.jpeds.2007.09.019
10.1111/j.2041-1014.2009.00562.x
10.1016/j.archoralbio.2014.09.002
10.1159/000358904
10.1590/1677-3225v14n2a02
10.1111/jcpe.12528
10.1016/j.celrep.2016.12.047
10.1093/rheumatology/kem112
10.1111/jcpe.12936
10.14238/sp16.4.2014.292-8
10.21776/ub.eprodenta.2018.002.01.2
10.1371/journal.pone.0170209
10.1111/j.1600-0757.2012.00446.x
ContentType Journal Article
Copyright 2019 The Authors
2019 The Authors.
2019 The Authors 2019
Copyright_xml – notice: 2019 The Authors
– notice: 2019 The Authors.
– notice: 2019 The Authors 2019
DBID 6I.
AAFTH
AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.1016/j.jtumed.2019.09.005
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList

PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1658-3612
EndPage 565
ExternalDocumentID oai_doaj_org_article_354e6a92ca444631842801c0a7e6b193
PMC6940663
31908645
10_1016_j_jtumed_2019_09_005
S1658361219301088
Genre Journal Article
GroupedDBID ---
0R~
0SF
4.4
457
5VS
6I.
AACTN
AAEDT
AAEDW
AAFTH
AAIKJ
AALRI
AAXUO
ABMAC
ACGFS
ADEZE
AEXQZ
AFTJW
AGHFR
AITUG
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
EBS
EJD
FDB
GROUPED_DOAJ
HYE
HZ~
IPNFZ
IXB
KQ8
M41
M~E
NCXOZ
O-L
O9-
OK1
RIG
ROL
RPM
SSZ
W2D
AAYWO
AAYXX
ACVFH
ADCNI
ADVLN
AEUPX
AFPUW
AIGII
AKBMS
AKRWK
AKYEP
CITATION
NPM
7X8
5PM
ID FETCH-LOGICAL-c529t-88f66771ee5c982a349a05d7acf69680281f8bda620091c8426a677e69b401c93
IEDL.DBID IXB
ISSN 1658-3612
IngestDate Wed Aug 27 01:26:27 EDT 2025
Thu Aug 21 18:33:37 EDT 2025
Fri Jul 11 00:04:23 EDT 2025
Mon Jul 21 06:03:51 EDT 2025
Tue Jul 01 03:12:33 EDT 2025
Thu Apr 24 22:55:23 EDT 2025
Thu Jul 20 20:17:05 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords مقايسة الممتز المناعي المرتبط بالإنزيم (إلايسا)
IFN-γ
Periodontitis
المضاد الضوئي المناعي
الأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة
SLE
الذئبة الحمامية المجموعية
التهاب اللثة
Anti-dsDNA antibody
ELISA
Language English
License This is an open access article under the CC BY-NC-ND license.
2019 The Authors.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c529t-88f66771ee5c982a349a05d7acf69680281f8bda620091c8426a677e69b401c93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S1658361219301088
PMID 31908645
PQID 2334269931
PQPubID 23479
PageCount 6
ParticipantIDs doaj_primary_oai_doaj_org_article_354e6a92ca444631842801c0a7e6b193
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6940663
proquest_miscellaneous_2334269931
pubmed_primary_31908645
crossref_citationtrail_10_1016_j_jtumed_2019_09_005
crossref_primary_10_1016_j_jtumed_2019_09_005
elsevier_sciencedirect_doi_10_1016_j_jtumed_2019_09_005
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-12-01
PublicationDateYYYYMMDD 2019-12-01
PublicationDate_xml – month: 12
  year: 2019
  text: 2019-12-01
  day: 01
PublicationDecade 2010
PublicationPlace Saudi Arabia
PublicationPlace_xml – name: Saudi Arabia
PublicationTitle Journal of Taibah University Medical Sciences
PublicationTitleAlternate J Taibah Univ Med Sci
PublicationYear 2019
Publisher Elsevier Ltd
Taibah University
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Taibah University
– name: Elsevier
References Isenberg, Manson, Ehrenstein (bib16) 2007; 46
Isaza-Guzmán, Cardona-Vélez, Gaviria-Correa (bib19) 2015; 60
Mizraji (bib20) 2017; 18
Nazir (bib1) 2017; 1
Rutter-Locher, Fuggle, Orlandi (bib4) 2017; 6
Hajishengallis (bib6) 2010; 25
Hajishengallis (bib12) 2014; 56
Fulop, Witkowsk, Pawelec, Alan, Larbi (bib7) 2014; 39
Nainar, Alamelu, Arun, dan Rajasekaran (bib17) 2016; 1
Lemos, Gurgel, dan Freitas (bib18) 2015; 14
Saleh, Kurniati, dan Syarif (bib14) 2016; 16
Beltrán-Aguilar, Eke, Thornton-Evans, Petersen (bib8) 2012; 60
Salama, Matthew, Masashi (bib5) 2014; 28
Etchegaray-Morales, Méndez-Martínez, Jiménez-Hernández, Mendoza-Pinto, Alonso-García, Montiel-Jarquín (bib9) 2017; 12
Hiraki, Benseler, Tyrrell (bib15) 2008; 152
Pandruvada, Gonzalez, Kirakodu, Gudhimella, Stromberg, Ebersole, Orraca, Gonzalez-Martinez, Novak, Huja (bib13) 2016; 43
Mukaka (bib11) 2012; 24
Diah, Nugreheni (bib3) 2018; 2
Gan, Patel (bib10) 2013; 133
Lang, Bartold (bib2) 2018; 45
Rutter-Locher (10.1016/j.jtumed.2019.09.005_bib4) 2017; 6
Pandruvada (10.1016/j.jtumed.2019.09.005_bib13) 2016; 43
Mukaka (10.1016/j.jtumed.2019.09.005_bib11) 2012; 24
Nazir (10.1016/j.jtumed.2019.09.005_bib1) 2017; 1
Hajishengallis (10.1016/j.jtumed.2019.09.005_bib6) 2010; 25
Etchegaray-Morales (10.1016/j.jtumed.2019.09.005_bib9) 2017; 12
Isaza-Guzmán (10.1016/j.jtumed.2019.09.005_bib19) 2015; 60
Lemos (10.1016/j.jtumed.2019.09.005_bib18) 2015; 14
Gan (10.1016/j.jtumed.2019.09.005_bib10) 2013; 133
Fulop (10.1016/j.jtumed.2019.09.005_bib7) 2014; 39
Mizraji (10.1016/j.jtumed.2019.09.005_bib20) 2017; 18
Saleh (10.1016/j.jtumed.2019.09.005_bib14) 2016; 16
Beltrán-Aguilar (10.1016/j.jtumed.2019.09.005_bib8) 2012; 60
Hajishengallis (10.1016/j.jtumed.2019.09.005_bib12) 2014; 56
Hiraki (10.1016/j.jtumed.2019.09.005_bib15) 2008; 152
Lang (10.1016/j.jtumed.2019.09.005_bib2) 2018; 45
Isenberg (10.1016/j.jtumed.2019.09.005_bib16) 2007; 46
Salama (10.1016/j.jtumed.2019.09.005_bib5) 2014; 28
Diah (10.1016/j.jtumed.2019.09.005_bib3) 2018; 2
Nainar (10.1016/j.jtumed.2019.09.005_bib17) 2016; 1
References_xml – volume: 152
  start-page: 550
  year: 2008
  end-page: 556
  ident: bib15
  article-title: Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study
  publication-title: J Pediatr
– volume: 56
  start-page: 30
  year: 2014
  end-page: 37
  ident: bib12
  article-title: Aging and its impact on innate immunity and inflammation: implications for periodontitis
  publication-title: J Oral Biosci
– volume: 14
  start-page: 106
  year: 2015
  end-page: 111
  ident: bib18
  article-title: Th2 cells and the IFN-γ R1 subunit in early and advanced experimental periodontitis in rats; an immunohistochemical study
  publication-title: Braz J Oral Sci
– volume: 1
  start-page: 70
  year: 2016
  end-page: 75
  ident: bib17
  article-title: Immunological profile of periapical and periodontal lesions: current concept in the role of T cells
  publication-title: J Oper Dent Endod
– volume: 45
  start-page: S9
  year: 2018
  end-page: S16
  ident: bib2
  article-title: Periodontal health
  publication-title: J Clin Periodontol
– volume: 2
  start-page: 108
  year: 2018
  end-page: 115
  ident: bib3
  article-title: Difference gingivitis total incidence between pre-puberty and puberty age in Malang
  publication-title: E-Prodenta Journal of Dentistry
– volume: 16
  start-page: 292
  year: 2016
  end-page: 298
  ident: bib14
  article-title: Assesment of systemic lupus erytematous using SLEDAI score in pediatric department RSCM jakarta Indonesia
  publication-title: Sari Pediatri
– volume: 60
  start-page: 91
  year: 2015
  end-page: 99
  ident: bib19
  article-title: Association study between salivary levels of interferon (IFN)-gamma, interleukin (IL)-17, IL-21, and IL-22 with chronic periodontitis
  publication-title: Arch Oral Biol
– volume: 1
  start-page: 72
  year: 2017
  end-page: 80
  ident: bib1
  article-title: Prevalence of periodontal disease, its association with systemic diseases and prevention
  publication-title: Int J Health Sci
– volume: 28
  start-page: 99
  year: 2014
  end-page: 114
  ident: bib5
  article-title: Cellular senescence and its effector programs
  publication-title: Genes Dev
– volume: 39
  start-page: 163
  year: 2014
  end-page: 176
  ident: bib7
  article-title: On the immunological theory of aging
  publication-title: Aging: Facts and Theories
– volume: 46
  start-page: 1052
  year: 2007
  end-page: 1056
  ident: bib16
  article-title: Fifty years of anti-dsDNA antibodies: are we approaching journey's end?
  publication-title: Rheumatology
– volume: 60
  start-page: 40
  year: 2012
  end-page: 53
  ident: bib8
  article-title: Recording and surveillance systems for periodontal diseases
  publication-title: Periodontology 2000
– volume: 25
  start-page: 25
  year: 2010
  end-page: 37
  ident: bib6
  article-title: Too old to fight? Aging and its toll on innate immunity
  publication-title: Molecular Oral Microbiology
– volume: 18
  start-page: 419
  year: 2017
  end-page: 431
  ident: bib20
  article-title: Cell reports porphyromonas gingivalis promotes unrestrained type I interferon production by dysregulating TAM signaling via MYD88 degradation
  publication-title: Cell Rep
– volume: 12
  year: 2017
  ident: bib9
  article-title: Factors associated with health-related quality of life in Mexican lupus patients using the LupusQol
  publication-title: PLoS One
– volume: 6
  start-page: 127
  year: 2017
  end-page: 129
  ident: bib4
  article-title: Periodontal disease and autoimmunity: what we have learned from microbiome in rheumatology
  publication-title: J intech
– volume: 43
  start-page: 408
  year: 2016
  end-page: 417
  ident: bib13
  article-title: Bone biology-related gingival transcriptome in ageing and periodontitis in non-human primates
  publication-title: J Clin Periodontol
– volume: 133
  start-page: 54
  year: 2013
  end-page: 59
  ident: bib10
  article-title: Enzyme immunoassay and enzyme-linked immunosorbent assay
  publication-title: J Investig Dermatol
– volume: 24
  start-page: 69
  year: 2012
  end-page: 71
  ident: bib11
  article-title: A guide to appropriate use of Correlation coefficient in medical research
  publication-title: Malawi Med J: The Journal of Medical Association of Malawi
– volume: 6
  start-page: 127
  year: 2017
  ident: 10.1016/j.jtumed.2019.09.005_bib4
  article-title: Periodontal disease and autoimmunity: what we have learned from microbiome in rheumatology
  publication-title: J intech
– volume: 28
  start-page: 99
  year: 2014
  ident: 10.1016/j.jtumed.2019.09.005_bib5
  article-title: Cellular senescence and its effector programs
  publication-title: Genes Dev
  doi: 10.1101/gad.235184.113
– volume: 24
  start-page: 69
  issue: 3
  year: 2012
  ident: 10.1016/j.jtumed.2019.09.005_bib11
  article-title: A guide to appropriate use of Correlation coefficient in medical research
  publication-title: Malawi Med J: The Journal of Medical Association of Malawi
– volume: 56
  start-page: 30
  issue: 1
  year: 2014
  ident: 10.1016/j.jtumed.2019.09.005_bib12
  article-title: Aging and its impact on innate immunity and inflammation: implications for periodontitis
  publication-title: J Oral Biosci
– volume: 152
  start-page: 550
  issue: 4
  year: 2008
  ident: 10.1016/j.jtumed.2019.09.005_bib15
  article-title: Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study
  publication-title: J Pediatr
  doi: 10.1016/j.jpeds.2007.09.019
– volume: 25
  start-page: 25
  year: 2010
  ident: 10.1016/j.jtumed.2019.09.005_bib6
  article-title: Too old to fight? Aging and its toll on innate immunity
  publication-title: Molecular Oral Microbiology
  doi: 10.1111/j.2041-1014.2009.00562.x
– volume: 60
  start-page: 91
  issue: 1
  year: 2015
  ident: 10.1016/j.jtumed.2019.09.005_bib19
  article-title: Association study between salivary levels of interferon (IFN)-gamma, interleukin (IL)-17, IL-21, and IL-22 with chronic periodontitis
  publication-title: Arch Oral Biol
  doi: 10.1016/j.archoralbio.2014.09.002
– volume: 39
  start-page: 163
  year: 2014
  ident: 10.1016/j.jtumed.2019.09.005_bib7
  article-title: On the immunological theory of aging
  publication-title: Aging: Facts and Theories
  doi: 10.1159/000358904
– volume: 14
  start-page: 106
  issue: 2
  year: 2015
  ident: 10.1016/j.jtumed.2019.09.005_bib18
  article-title: Th2 cells and the IFN-γ R1 subunit in early and advanced experimental periodontitis in rats; an immunohistochemical study
  publication-title: Braz J Oral Sci
  doi: 10.1590/1677-3225v14n2a02
– volume: 1
  start-page: 72
  issue: 2
  year: 2017
  ident: 10.1016/j.jtumed.2019.09.005_bib1
  article-title: Prevalence of periodontal disease, its association with systemic diseases and prevention
  publication-title: Int J Health Sci
– volume: 43
  start-page: 408
  year: 2016
  ident: 10.1016/j.jtumed.2019.09.005_bib13
  article-title: Bone biology-related gingival transcriptome in ageing and periodontitis in non-human primates
  publication-title: J Clin Periodontol
  doi: 10.1111/jcpe.12528
– volume: 1
  start-page: 70
  issue: 2
  year: 2016
  ident: 10.1016/j.jtumed.2019.09.005_bib17
  article-title: Immunological profile of periapical and periodontal lesions: current concept in the role of T cells
  publication-title: J Oper Dent Endod
– volume: 18
  start-page: 419
  year: 2017
  ident: 10.1016/j.jtumed.2019.09.005_bib20
  article-title: Cell reports porphyromonas gingivalis promotes unrestrained type I interferon production by dysregulating TAM signaling via MYD88 degradation
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2016.12.047
– volume: 46
  start-page: 1052
  issue: 7
  year: 2007
  ident: 10.1016/j.jtumed.2019.09.005_bib16
  article-title: Fifty years of anti-dsDNA antibodies: are we approaching journey's end?
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kem112
– volume: 45
  start-page: S9
  year: 2018
  ident: 10.1016/j.jtumed.2019.09.005_bib2
  article-title: Periodontal health
  publication-title: J Clin Periodontol
  doi: 10.1111/jcpe.12936
– volume: 16
  start-page: 292
  issue: 4
  year: 2016
  ident: 10.1016/j.jtumed.2019.09.005_bib14
  article-title: Assesment of systemic lupus erytematous using SLEDAI score in pediatric department RSCM jakarta Indonesia
  publication-title: Sari Pediatri
  doi: 10.14238/sp16.4.2014.292-8
– volume: 2
  start-page: 108
  issue: 1
  year: 2018
  ident: 10.1016/j.jtumed.2019.09.005_bib3
  article-title: Difference gingivitis total incidence between pre-puberty and puberty age in Malang
  publication-title: E-Prodenta Journal of Dentistry
  doi: 10.21776/ub.eprodenta.2018.002.01.2
– volume: 133
  start-page: 54
  issue: 12
  year: 2013
  ident: 10.1016/j.jtumed.2019.09.005_bib10
  article-title: Enzyme immunoassay and enzyme-linked immunosorbent assay
  publication-title: J Investig Dermatol
– volume: 12
  issue: 1
  year: 2017
  ident: 10.1016/j.jtumed.2019.09.005_bib9
  article-title: Factors associated with health-related quality of life in Mexican lupus patients using the LupusQol
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0170209
– volume: 60
  start-page: 40
  issue: 1
  year: 2012
  ident: 10.1016/j.jtumed.2019.09.005_bib8
  article-title: Recording and surveillance systems for periodontal diseases
  publication-title: Periodontology 2000
  doi: 10.1111/j.1600-0757.2012.00446.x
SSID ssj0001105222
Score 2.170101
Snippet لتحليل توافق شدة التهاب اللثة مع نشاط المرض، والأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة والمضاد الضوئي المناعي في مرضى الذئبة الحمامية...
To analyse the correlation between periodontitis severity and disease activity, anti-double stranded DNA (anti-dsDNA) antibody, and interferon-gamma (IFN-γ)...
الملخص: أهداف البحث: لتحليل توافق شدة التهاب اللثة مع نشاط المرض، والأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة والمضاد الضوئي المناعي في مرضى...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 560
SubjectTerms Anti-dsDNA antibody
ELISA
IFN-γ
Original
Periodontitis
SLE
الأجسام المضادة لـلحمض النووي الريبي المختزل مزدوج الضفيرة
التهاب اللثة
الذئبة الحمامية المجموعية
المضاد الضوئي المناعي
مقايسة الممتز المناعي المرتبط بالإنزيم (إلايسا)
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQHhAXxJvykpG4WuThOPFxeaxWSKw4sNLerLFjQ1fdZNUkB34O_5QZO6laOPSClF5qp44748w3nvE3jL0LCiDUCnAh6ULI3LZCQ9BCWldYcKEqXcy2uFDnl_LLVXW1V-qLcsISPXD6496XlfQKdOFAoueCGoh4OctdBrVXFtEHvX3R5u05U3F3BWFDCiHkaGJFiXZ8OTcXk7uuR1z5RBSa60hzStXr9uxSpO8_ME__ws-_syj3zNLZA3Z_xpP8NM3jIbvju0fs7tc5Yv6Y_f6GKoauZ6ROHTheMAvEt5w2YfkcouH4DJ4q2XHoWvyMa9H2k91gA45L--T808VpbLB9m3oR18Q2-G3fiR9wcwN8QylIOErHZ77WIY2R-KLXjm-m22ngfvsrkcX2wzQ8YZdnn79_PBdzWQbhqkKPommCUnWde1853RRQSg1Z1dYoWWLaQcCSh8a2oCjwkjsUmALs75W26Mw5XT5lJ13f-ed0YLxotbdgQ91IW_km-LqBrAkyOJ21fsXKRSjGzZzlVDpjY5bktGuTRGlIlCbDK6tWTOzuuk2cHUf6fyB57_oS43b8AvXQzHpojunhitWLtpgZvCRQgj-1PjL820W5DK5tCthA5_tpMEVZ0kljXeYr9iwp2-4h8dWJ3qjEu-sDNTyYxWFLt_4Z-cOVlgQ0X_yPab9k92gqKcHnFTsZt5N_jTBttG_iivwDCto9hA
  priority: 102
  providerName: Directory of Open Access Journals
Title Periodontitis is associated with disease severity and anti-double stranded DNA antibody and interferon-gamma levels in patients with systemic lupus erythematosus
URI https://dx.doi.org/10.1016/j.jtumed.2019.09.005
https://www.ncbi.nlm.nih.gov/pubmed/31908645
https://www.proquest.com/docview/2334269931
https://pubmed.ncbi.nlm.nih.gov/PMC6940663
https://doaj.org/article/354e6a92ca444631842801c0a7e6b193
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhh9JL6bvbR1ChV7F-yA8dk7QhFBoKbWBvRpKl1GFjL34c-nPyTzMjydu4PQQK3sNa0kraGY1mNDOfCPlkcyltkUtYSCJhPFY1E9IKxpVOlNQ2S7WLtrjIzy_51022OSCncy4MhlUG2e9lupPW4c06_JvrXdOsf8SweaYIgCWASWGxgBxOeemS-DYnf85ZQIHwzgSsz7DBnEHnwryuR5ABCBkaCwd4ivfY3duhHJD_YqP6VxH9O57y3gZ19pQ8CZolPfaDf0YOTPucPPoWfOcvyO13YDYwQh2I6kDhkYE0pqZ4HEuDs4bCGAzeaUdlW8NnbFjdTWoLBdAvnpjTzxfHrkB1ta-FqBO9NX3Xsit5cyPpFoORoJeWBuTWwffhkaMbTbfTbhqo6X972NhumIaX5PLsy8_TcxYuaGA6S8TIytLmeVHExmRalIlMuZBRVhdAY8TcAdUltqWqZY4umFiXoA1IqG9yocCs0yJ9RQ7brjVvMHU8qYVRUtmi5CozpTVFKaPScqtFVJsVSWeiVDqgl-MlGttqDlO7rjwpKyRlFcETZSvC9q12Hr3jgfonSO99XcTedi-6_qoKzFelGTe5FImWHGxpkIlgwcFsIgkTU8CMK1LM3FItWBl-qnmg-48zc1WwytF1I1vTTUOVpCnmHIs0XpHXntn2gwQhCnYph9bFgg0Xs1iWtM0vhySeC44q59v_HvE78hi_-fie9-Rw7CfzAbS0UR25040jtxjvAAqSQUQ
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkYAL4s3yNBLXaPN04mNbqLbQrpBopb1ZtmOXVNtklceBn8M_ZSZ2li4cKiFlL7G9tjOfxzP2-DMhHy2T0uZMwkDicZBGqgy4tDxIlY6V1DZL9BhtsWSLi_TLKlvtkaPpLAyGVXrd73T6qK39m7n_mvNNVc2_RzB5JkiAxQGkMFjukLtgDTCE9snq8M9CC1gQbjcBCwRYYjpCN8Z5XfWgBJAzNOIj4yleZHdjihqZ_Hdmqn8t0b8DKm_MUMePyENvWtID1_rHZM_UT8i9M795_pT8-gZoAy90ZFHtKDzSy8aUFNdjqd-todAGg5faUVmX8OuroGwGtYYEqBeXzOmn5cGYoJrS5ULaidaatqmDS3l9Lekao5Gglpp66tbO1eGooytN18Nm6Khpfzre2KYbumfk4vjz-dEi8Dc0BDqLeR8UhWUszyNjMs2LWCYpl2FW5iBkJN0B2yWyhSolwz2YSBdgDkjIbxhX4Ndpnjwn-3VTm5d4djwuuVFS2bxIVWYKa_JChoVNreZhaWYkmYQitKcvx1s01mKKU7sSTpQCRSlCeMJsRoJtqY2j77gl_yHKe5sXybfHF017KTz6RJKlhkkea5mCMw1KEVw46E0ooWMK0Dgj-YQWsYNl-Kvqluo_TOASMMxx70bWphk6EScJHjrmSTQjLxzYto0ELQqOaQql8x0Y7vRiN6WufoxU4oynaHO--u8Wvyf3F-dnp-L0ZPn1NXmAKS7Y5w3Z79vBvAWTrVfvxiH5G6txQ3Y
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Periodontitis+is+associated+with+disease+severity+and+anti-double+stranded+DNA+antibody+and+interferon-gamma+levels+in+patients+with+systemic+lupus+erythematosus&rft.jtitle=Journal+of+Taibah+University+Medical+Sciences&rft.au=Gofur%2C+Nanda+R+P&rft.au=Nurdiana%2C+Nurdiana&rft.au=Kalim%2C+Handono&rft.au=Handono%2C+Kusworini&rft.date=2019-12-01&rft.eissn=1658-3612&rft.volume=14&rft.issue=6&rft.spage=560&rft_id=info:doi/10.1016%2Fj.jtumed.2019.09.005&rft_id=info%3Apmid%2F31908645&rft.externalDocID=31908645
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1658-3612&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1658-3612&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1658-3612&client=summon